Micromet to offer shares of common stock

NewsGuard 100/100 Score

Micromet, Inc. (NASDAQ:MITI) announced today that it intends, subject to market and other conditions, to offer shares of its common stock pursuant to an underwriting agreement with Piper Jaffray & Co. Piper Jaffray is acting as sole underwriter for this offering.

The Company plans to use the net proceeds from the financing primarily for general corporate purposes, which may include research and development, capital expenditures, working capital and general and administrative expenses. Closing of the offering is expected to occur on or about November 16, 2010, subject to the satisfaction of customary closing conditions.

The shares will be offered and sold pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission.

Information about the offering will be available in a prospectus supplement to be filed with the Securities and Exchange Commission. Copies of the prospectus supplement and prospectus, when available, may be obtained from Piper Jaffray & Co., 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402, Telephone 1-800-747-3924. Before you invest, you should read the base prospectus in the shelf registration statement, the prospectus supplement, when available, and other documents the Company has filed with the Securities and Exchange Commission for more complete information about the Company and the offering.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy the Company's common stock, nor shall there be any sale of the common stock in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction. Any offer, if at all, will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective shelf registration statement.

Source: Micromet, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.